• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, April 25

Dr Reddy's Laboratories Ltd has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolpidem Tartrate tablets, 5 mg and 10 mg. The product is being shipped immediately, according to a press release issued here on Wednesday.

Zolpidem Tartrate tablets are the generic version of Sanofi-Aventis Ambien tablets. Ambien tablets had US sales of approximately $2.1 billion for the same strengths for 2006 according to IMS Health, the release added.

More Stories on : Announcements | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
USFDA nod for Dr Reddy's Zolpidem

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line